Bernstein upgraded Takeda (TAK) to Outperform from Market Perform with a price target of 6,900 yen, up from 5,100 yen, citing “bold” cost cuts and multiple upcoming de-risking events for the pipeline.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TAK:
- Denali Therapeutics regains full rights to DNL593
- Abivax appoints Michael Nesrallah as chief commercial officer
- Axsome Therapeutics enters TAK-063 asset purchase agreement with Takeda
- Alumis shares should trade higher on ‘major success’ at AAD, says Ramond James
- Alumis price target raised to $55 from $50 at Oppenheimer